Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
L Xu, Y Li, Y Dai, J Peng - Pharmacological research, 2018 - Elsevier
Epidemiological studies have implied that diabetes mellitus (DM) will become an epidemic
accompany with metabolic and endocrine disorders worldwide. Most of DM patients are …
accompany with metabolic and endocrine disorders worldwide. Most of DM patients are …
Body weight considerations in the management of type 2 diabetes
CM Apovian, J Okemah, PM O'Neil - Advances in therapy, 2019 - Springer
Obesity is one of the main risk factors for type 2 diabetes (T2D), representing a major
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, Y Handelsman, G Grunberger, D Einhorn… - Endocrine Practice, 2020 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ABCD= adiposity-based chronic disease; ACCORD= Action to Control …
Endocrinologists; ABCD= adiposity-based chronic disease; ACCORD= Action to Control …
[HTML][HTML] Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
FS Willard, JD Douros, MBN Gabe, AD Showalter… - JCI insight, 2020 - ncbi.nlm.nih.gov
Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist under development for
the treatment of type 2 diabetes mellitus (T2DM), obesity, and nonalcoholic steatohepatitis …
the treatment of type 2 diabetes mellitus (T2DM), obesity, and nonalcoholic steatohepatitis …
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine Practice, 2019 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine Practice, 2017 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C AACE= American Association of Clinical
Endocrinologists ACCORD= Action to Control Cardiovascular Risk in Diabetes ACCORD …
Endocrinologists ACCORD= Action to Control Cardiovascular Risk in Diabetes ACCORD …
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine practice, 2018 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020Table. No title available.
R Chawla, SV Madhu, BM Makkar… - Indian journal of …, 2020 - journals.lww.com
Guidelines RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2
Diabetes Mellitus 2020Table. No title available.
Diabetes Mellitus 2020Table. No title available.
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine Practice, 2016 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C AACE= American Association of Clinical
Endocrinologists ACCORD= Action to Control Cardiovascular Risk in Diabetes ACCORD …
Endocrinologists ACCORD= Action to Control Cardiovascular Risk in Diabetes ACCORD …
Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes
HJ Lambers Heerspink, D De Zeeuw… - Diabetes, Obesity …, 2013 - Wiley Online Library
Aims Sodium–glucose co‐transporter 2 (SGLT2) reabsorbs glucose and sodium in the renal
proximal tubule. Dapagliflozin, an SGLT2 inhibitor, targets hyperglycaemia in type 2 …
proximal tubule. Dapagliflozin, an SGLT2 inhibitor, targets hyperglycaemia in type 2 …